Patient Choice, one of the most popular one-stop-shop for registered medical cannabis patients to purchase their medicine, has recently made an announcement that it is partnering with trusted and robust producers of high-quality medical cannabis. Patient Choice's main motto is to provide patients with convenient access to fairly priced and high-quality medical cannabis. Co-Founder & Chief Operations Officer of Patient Choice, Andrew Richard, has stated that the new partnership with quality producers is to increase their continued efforts to give their patients superior medical cannabis. Larry Dykstra of Dykstra Greenhouses has stated that partnering with Patient Choice has given them an opportunity to focus more on growing superior products, and it has been a dream partnership for his company.
The three companies to partner with Patient Choice are Lupos Biotechnology, Parkland Flower, and Dykstra Greenhouses. Lupos Biotechnology received its license from Health Canada in 2018, and it is the sole processer responsible for the production of oils. Parkland Flower has a history going back to 60 years, and they are into cultivating limited edition, rare FPOG. Dykstra Greenhouses is a family-run business and has been active for 30 years. CEO of Lupos Biotech, John King, has stated that the new opportunity is wonderful, and the company is keen on joining the popular medical platform.